You're receiving this email because you're subscribed to Ring the Bell from Benzinga. To manage your subscription, click the link at the bottom of this email.

Happy Thursday Zingernation! Kids these days will never understand the struggle of powering up the one computer in the house and waiting for dial-up internet to fire up. Pretty much everywhere has WiFi now, and soon, you might even be able to get a mini satellite dish that can fit in your backpack.

—Aaron Bry & Nic Chahine

Plus, this options expert grew his portfolio more than 140% in less than two weeks… here’s how.

MARKET SNAPSHOT

On Tuesday: I know, I know, I’m starting to sound like a broken record. But the market made new all-time highs, led by what else other than chip stocks like NVIDIA.

On Our Radar: Initial jobless claims, building permits and housing starts all due this morning at 8:30 am ET.

TOP STORY

Wall Street On Track To Resume Meteoric Climb, Nvidia Builds On Gains

Briefly: U.S. stocks will likely carry over from where they left off as the market reopens after the Juneteenth holiday on Thursday. The major index futures were all uniformly higher, underpinned by the continued buoyancy in the tech space.

So: The sector’s accelerated runup, though, has caused concerns among certain quarters. Analysts have begun calling for moderation in sentiment toward the space once the Federal Reserve confirms rate cuts for the year.

Basically: Traders may also keep an eye on some key Main Street catalysts such as the jobless claims and housing starts data and the results of a regional manufacturing survey. Here’s where investors are putting their money as we head into Thursday’s open.

PRESENTED BY SIMPLERTRADING

A 147% Gain in Only TWO Weeks?

What’s the secret to Taylor Horton’s account growing 147% in two weeks? That’s exactly what he covered in his live demo. Imagine no more FOMO, no more chasing trades, or stressing about market conditions. That’s just part of the payoff for only taking “A+ Setups.”

You’re probably wondering what an “A+ Setup” is. They’re so objective that members of Taylor’s Compounding Growth Mastery are able to identify the same trades. See why Tayor can’t wait to spell out exactly how he can identify and execute 7 out of 10 trades successfully.

Watch the demo to get the full details…

FIVE ZINGERS

Can’t Stop Won’t Stop: $NVDA looks set to further its gap from $MSFT and $AAPL as the most valuable company in the world. Here’s what’s going on.

Data Breach: A cyberattack impacted thousands of car dealerships Wednesday, impacting thousands of locations.

Heating Up: Hotter-than-usual temperatures to start the summer are putting these energy names in the investor spotlight.

Skinny Drugs, Fat Gains: Eli Lilly is working to protect its profits from weight-loss drugs by fighting back against counterfeits hitting the market.

Is $500k Enough?: The recommended retirement savings amount is $550K, so why are so many Americans are falling short?

ONE FOR THE ROAD

Accenture Stock Shoots Up After Q3 Print, CEO Highlights $2B in Generative AI Sales

Briefly: Accenture reported third-quarter fiscal 2024 sales of $16.47 billion compared with the analyst consensus of $16.55 billion, down 1% Y/Y in U.S. dollars and up by 1.4% in local currency.

So: Revenues were slightly above the midpoint of the company’s guided range of $16.10 billion – $16.70 billion. Adjusted EPS of $3.13 missed the analyst consensus of $3.15.

Basically: Revenues for the quarter reflect a negative foreign exchange impact of approximately 2%, compared with the negative 1% impact previously assumed.

And: New bookings for the quarter were $21.06 billion, with consulting bookings of $9.28 billion and managed services bookings of $11.78 billion. Here’s what analysts are saying about the tech consulting play.

JOIN US TODAY AT 11AM ET

Healthcare and Biotech Breakthroughs

TODAY: THURSDAY, JUNE 20 | 11:00 AM EST

Discover the future of healthcare with Healthcare & Biotech Breakthroughs. Dive into the latest innovations driving healthcare forward and explore the vast investment opportunities in healthcare and biotech. Join us to discover how these breakthroughs are reshaping patient care and shaping the landscape of healthcare. Don’t miss out on being part of the healthcare revolution – register now!

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Mining Weekly: Get an insider's edge with news, analysis, and commentary on what’s shaping the mining and commodities industry that powers the global economy. Subscribe here.